Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Long-lived particles at the energy frontier: the MATHUSLA physics case.

Curtin D, Drewes M, McCullough M, Meade P, Mohapatra RN, Shelton J, Shuve B, Accomando E, Alpigiani C, Antusch S, Carlos Arteaga-Velázquez J, Batell B, Bauer M, Blinov N, Salomé Caballero-Mora K, Hyeok Chang J, Chun EJ, Co RT, Cohen T, Cox P, Craig N, Csáki C, Cui Y, D'Eramo F, Delle Rose L, Bhupal Dev PS, Dienes KR, Dror JA, Essig R, Evans JA, Evans JL, Fernández Tellez A, Fischer O, Flacke T, Fradette A, Frugiuele C, Fuchs E, Gherghetta T, Giudice GF, Gorbunov D, Gupta RS, Hagedorn C, Hall LJ, Harris P, Carlos Helo J, Hirsch M, Hochberg Y, Hook A, Ibarra A, Ipek S, Jung S, Knapen S, Kuflik E, Liu Z, Lombardo S, Lubatti HJ, McKeen D, Molinaro E, Moretti S, Nagata N, Neubert M, Miguel No J, Olaiya E, Perez G, Peskin ME, Pinner D, Pospelov M, Reece M, Robinson DJ, Rodríguez Cahuantzi M, Santonico R, Schlaffer M, Shepherd-Themistocleous CH, Spray A, Stolarski D, Subieta Vasquez MA, Sundrum R, Thamm A, Thomas B, Tsai Y, Tweedie B, West SM, Young C, Yu F, Zaldivar B, Zhang Y, Zurek K, Zurita J.

Rep Prog Phys. 2019 Nov;82(11):116201. doi: 10.1088/1361-6633/ab28d6. Epub 2019 Jun 11.

PMID:
31185458
2.

Widespread Antibiotic, Biocide, and Metal Resistance in Microbial Communities Inhabiting a Municipal Waste Environment and Anthropogenically Impacted River.

Collins-Fairclough AM, Co R, Ellis MC, Hug LA.

mSphere. 2018 Sep 26;3(5). pii: e00346-18. doi: 10.1128/mSphere.00346-18.

3.

QCD Axion Dark Matter with a Small Decay Constant.

Co RT, Hall LJ, Harigaya K.

Phys Rev Lett. 2018 May 25;120(21):211602. doi: 10.1103/PhysRevLett.120.211602.

4.

A Pilot Randomized Controlled Trial of a New Supplementary Food Designed to Enhance Cognitive Performance during Prevention and Treatment of Malnutrition in Childhood.

Roberts SB, Franceschini MA, Krauss A, Lin PY, de Sa AB, Có R, Taylor S, Brown C, Chen O, Johnson EJ, Pruzensky W, Schlossman N, Balé C, Wu KT, Hagan K, Saltzman E, Muentener P.

Curr Dev Nutr. 2017 Nov;1(11). pii: e000885. doi: 10.3945/cdn.117.000885. Epub 2017 Oct 12.

5.

It Takes a Village: Microbial Communities Thrive through Interactions and Metabolic Handoffs.

Hug LA, Co R.

mSystems. 2018 Mar 13;3(2). pii: e00152-17. doi: 10.1128/mSystems.00152-17. eCollection 2018 Mar-Apr.

6.

Chiral Dark Sector.

Co RT, Harigaya K, Nomura Y.

Phys Rev Lett. 2017 Mar 10;118(10):101801. doi: 10.1103/PhysRevLett.118.101801. Epub 2017 Mar 7.

7.

A glass polyalkenoate cement carrier for bone morphogenetic proteins.

Alhalawani AM, Rodriguez O, Curran DJ, Co R, Kieran S, Arshad S, Keenan TJ, Wren AW, Crasto G, Peel SA, Towler MR.

J Mater Sci Mater Med. 2015 Mar;26(3):151. doi: 10.1007/s10856-015-5494-3. Epub 2015 Mar 14.

PMID:
25773232
8.

Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.

Li CP, Tong MJ, Hwang SJ, Luo JC, Co RL, Tsay SH, Chang FY, Lee SD.

J Gastroenterol Hepatol. 2000 Jan;15(1):95-8.

PMID:
10719755
9.

The changes in quantitative HCV RNA titers during interferon alpha 2B therapy in patients with chronic hepatitis C infection.

Tong MJ, Blatt LM, Conrad A, Hur Y, Russell J, El-Farra NS, Co RL.

Am J Gastroenterol. 1998 Apr;93(4):601-5.

PMID:
9576455
10.
11.

Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA.

Hwang SJ, Lee SD, Lu RH, Chan CY, Lai L, Co RL, Tong MJ.

J Virol Methods. 1996 Dec;62(2):123-9.

PMID:
9002070
12.
13.

Tuberculosis patients. Who should we isolate?

Co RM, Ankobiah WA.

Chest. 1996 Oct;110(4):1128-9. No abstract available.

PMID:
8874291
14.

Clinical outcomes after transfusion-associated hepatitis C.

Tong MJ, el-Farra NS, Reikes AR, Co RL.

N Engl J Med. 1995 Jun 1;332(22):1463-6.

15.

A pilot, open-labelled, phase II study using oral ribavirin in the treatment of patients with chronic active hepatitis B.

Tong MJ, Hwang SJ, Lefkowitz M, Lee SD, Co RL, Lo KJ.

Clin Diagn Virol. 1995 May;3(4):377-85.

PMID:
15566819
16.

Evaluation of sexual transmission in patients with chronic hepatitis C infection.

Tong MJ, Lai PP, Hwang SJ, Lee SY, Co RL, Chien RN, Kuo G.

Clin Diagn Virol. 1995 Jan;3(1):39-47.

PMID:
15566786
17.

Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin.

Tong MJ, Hwang SJ, Lefkowitz M, Lee SD, Co RL, Conrad A, Schmid P, Lo KJ.

J Gastroenterol Hepatol. 1994 Nov-Dec;9(6):587-91.

PMID:
7865717
18.

Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma.

Tong MJ, Lee SY, Hwang SJ, Co RL, Lai PP, Chien D, Kuo G.

West J Med. 1994 Feb;160(2):133-8.

19.

Risk factors for hepatitis C virus infection among health care personnel in a community hospital.

Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ.

Am J Infect Control. 1993 Aug;21(4):196-200.

PMID:
7694529
20.

Hepatitis A vaccination.

Tong MJ, Co RL, Bellak C.

West J Med. 1993 Jun;158(6):602-5.

22.

Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.

Weissman JY, Tsuchiyose MM, Tong MJ, Co R, Chin K, Ettenger RB.

JAMA. 1988 Sep 23-30;260(12):1734-8.

PMID:
2970557
23.

A cost comparison analysis for screening and vaccination of hospital personnel with high- and low-prevalence hepatitis B virus antibodies in California.

Tong MJ, Co RL, Marci RD, Michaelson PM, Ortega G.

Infect Control Hosp Epidemiol. 1988 Feb;9(2):66-71.

PMID:
3125243
24.

Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis.

Tong MJ, Sampliner RE, Govindarajan S, Co RL.

Hepatology. 1987 Jul-Aug;7(4):713-8.

PMID:
3610049
26.

A hepatitis B vaccination program in a community teaching hospital.

Tong MJ, Howard AM, Schatz GC, Kane MA, Roskamp DA, Co RL, Boone C.

Infect Control. 1987 Mar;8(3):102-7.

PMID:
2952617
27.

Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma.

Nair PV, Tong MJ, Kempf R, Co R, Lee SD, Venturi CL.

Cancer. 1985 Sep 1;56(5):1018-22.

PMID:
2990662
28.

Hepatitis B virus markers in Asian families.

Tong MJ, Co RL.

Ann Intern Med. 1985 Aug;103(2):307-8. No abstract available.

PMID:
4014919
29.

Hepatitis B virus markers in the foreign-born Chinese population of Los Angeles, California.

Tong MJ, Yu M, Co R, Eastin B.

J Infect Dis. 1984 Mar;149(3):475. No abstract available.

PMID:
6715904
30.

Chemical modification or excision of neurophysin arginine-8 is associated with loss of peptide-binding ability.

Breslow E, Pagnozzi M, Co RT.

Biochem Biophys Res Commun. 1982 May 14;106(1):194-201. No abstract available.

PMID:
7103980
31.

Treatment of congestive heart failure in acute myocardial infarction.

Schwartz ML, Haider B, Co R.

J Am Osteopath Assoc. 1971 Feb;70(6):598-600. No abstract available.

PMID:
5204651
32.

Treatment of associated arrhythmias in acute myocardial infarction.

Schwartz ML, Haider B, Co R.

J Am Osteopath Assoc. 1971 Feb;70(6):597-8. No abstract available.

PMID:
5204650
33.

Antiarrhythmic effectiveness of alprenolol, a new beta adrenergic receptor blocking agent.

Schwartz ML, Haider B, Covino BG, Co RG.

J Electrocardiol. 1970;3(3-4):211-6. No abstract available.

PMID:
4397112
34.

First degree AV block.

Co RG.

Dis Chest. 1968 Dec;54(6):557-8. No abstract available.

PMID:
5722776

Supplemental Content

Support Center